Related Experiment Video

Updated: Jun 12, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Non-cystic fibrosis bronchiectasis: its diagnosis and management

Patrick Stafler1, Siobhán B Carr

  • 1Barts and The London Children's Hospital, UK.

Archives of Disease in Childhood. Education and Practice Edition
|May 27, 2010
PubMed

Insights

Diagnosing non-cystic fibrosis bronchiectasis in children is increasing due to better awareness and imaging. Early detection and treatment of pediatric bronchiectasis are crucial to prevent severe lung disease.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Non-cystic fibrosis bronchiectasis diagnosis in children is rising.
  • Increased disease awareness and high-resolution computed tomography (HRCT) availability contribute to this trend.
  • Common causes include infections, immunodeficiency, aspiration, and primary ciliary dyskinesia.

Purpose of the Study:

  • To review the pathogenesis and diagnosis of pediatric non-cystic fibrosis bronchiectasis.
  • To examine the evidence base for current treatment strategies.
  • To highlight the importance of early recognition in children with persistent productive cough.

Main Methods:

  • Literature review of pathogenesis, diagnosis, and treatment of pediatric bronchiectasis.
  • Analysis of diagnostic criteria and imaging modalities.
  • Evaluation of evidence for airway clearance, antibiotics, and targeted therapies.

Main Results:

  • Bronchiectasis diagnosis is increasing in children.
  • Key underlying conditions identified: infections, immunodeficiency, aspiration, primary ciliary dyskinesia.
  • Treatment involves airway clearance, antibiotics, and physiotherapy; some conditions have specific treatments.

Conclusions:

  • A high index of suspicion is needed for prolonged productive cough in children.
  • While classic bronchiectasis is irreversible, milder forms may show reversible radiographic changes.
  • Untreated severe bronchiectasis can lead to end-stage pulmonary failure.

More Related Videos

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History